From Africa to Western Australia, a group of ASX goldies is ramping up output or advancing projects towards near-term ...

Open-label extension trials provide long-term follow-up after a main trial and are an important part of drug development for ASX biotechs.

LinQ Minerals has been a standout performer among ASX juniors this year, as it looks to grow its massive NSW gold and copper ...

CEOs of smaller ASX biotechs are paying the price of trial failures, regulatory setbacks and difficult capital markets in ...

The ASX took a lunchtime beating as banks and miners slumped, with BHP's copper woes and NAB's job cuts adding to the pain.

Nurses, teachers and aged-care workers are among millions caught in a budget trap that lawyers say will force a national will ...

Icetana’s alliance with SoftBank Robotics is taking its AI surveillance software beyond CCTV, connecting incident detection ...

As prediction markets boom, ASX-listed InFocus eyes the action with its first Codexa customer and a conditional US$2.4m deal.

Resources investor Colin Petroulas has lifted his stake in Black Bear as it advances its Texas silver mine restart and Nevada ...

Côte d'Ivoire is only Africa's eighth biggest gold producer, but recent ASX winners show why it's one of the world's hottest ...

Energy and banks kept the ASX green while tech slipped again and takeover fever lit up Cleanaway and Challenger.

Skylark Minerals triples gold resources at Zaranou to 1.2Moz, Eminence acquiring five gold exploration projects in Côte d’Ivoire.